Equibles does not estimate personal net worth.
Get an email with a short summary when Fortrea Holdings Inc. publishes a filing, an earnings call transcript or a press release.
Get FTRE alertsJill McConnell is recorded as CFO at Fortrea Holdings Inc. (FTRE). The newest filing on record that lists Jill McConnell as CFO at Fortrea Holdings Inc. (FTRE) is dated April 27, 2026. Fortrea Holdings Inc. reported in an 8-K filed July 3, 2023 that Jill McConnell was appointed Chief Financial Officer. The proxy statement of Fortrea Holdings Inc. reports total compensation of $1,342,017 for Jill McConnell in fiscal 2024, including a base salary of $503,846. Disclosed compensation is on record for 3 fiscal years. Jill McConnell has spoken on 12 earnings calls and 1 other investor event across 1 company, most recently for Fortrea Holdings Inc. on July 29, 2026. Fortrea Holdings Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fortrea Holdings Inc. includes Anshul Thakral (CEO and Board Member), Peter M. Neupert (CEO and Board Member), Thomas Pike (CEO, Chairman and Board Member) and 7 others.
“Jill McConnell, the Chief Financial Officer of the Drug Development, Clinical Development and Commercialization Services business unit of Labcorp, will be appointed as our Chief Financial Officer in connection with the spinoff.”
“In my remarks, I will focus exclusively on our second quarter and year-to-date performance, as Anshul commented on guidance and outlook in his prepared remarks.”
“I mean, that is obviously the balance that you have to strike. And so every time we look at cost savings initiatives and as a people-based business, you know, you have to be mindful.”
“As Anshul stated, we delivered a solid first quarter. I am very proud of what the team achieved, and before getting into the details, I'd like to briefly highlight our progress against financial excellence, the third pillar of our growth strategy.”
“I want to begin by expressing gratitude to the entire Fortrea organization for our strong performance in 2025. We successfully navigated another year of significant change, thanks to the determination and resilience of our team.”
“In my prepared remarks, I'll cover the primary factors that influenced our third-quarter performance and share an update on our 2025 guidance. I'll highlight our progress against our previously shared cost optimization initiatives.”
Start not stated–present
Last confirmed April 27, 2026
Biotechnology · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Fortrea Holdings Inc. (FTRE) | Chief Financial Officer | $503,846 | $1,342,017 |
| 2023 | Fortrea Holdings Inc. (FTRE) | Chief Financial Officer | $455,607 | $3,078,795 |
| 2022 | Fortrea Holdings Inc. (FTRE) | Chief Financial Officer | $411,215 | $1,075,809 |
